These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33602107)

  • 21. Novel Targets for Parkinson's Disease: Addressing Different Therapeutic Paradigms and Conundrums.
    Rane P; Sarmah D; Bhute S; Kaur H; Goswami A; Kalia K; Borah A; Dave KR; Sharma N; Bhattacharya P
    ACS Chem Neurosci; 2019 Jan; 10(1):44-57. PubMed ID: 29957921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine D3 receptor: A neglected participant in Parkinson Disease pathogenesis and treatment?
    Yang P; Perlmutter JS; Benzinger TLS; Morris JC; Xu J
    Ageing Res Rev; 2020 Jan; 57():100994. PubMed ID: 31765822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Chinese herbal formula Liuwei dihuang protects dopaminergic neurons against Parkinson's toxin through enhancing antioxidative defense and preventing apoptotic death.
    Tseng YT; Chang FR; Lo YC
    Phytomedicine; 2014 Apr; 21(5):724-33. PubMed ID: 24411708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minocycline Rescues from Zinc-Induced Nigrostriatal Dopaminergic Neurodegeneration: Biochemical and Molecular Interventions.
    Kumar V; Singh BK; Chauhan AK; Singh D; Patel DK; Singh C
    Mol Neurobiol; 2016 Jul; 53(5):2761-2777. PubMed ID: 25764516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of oxidative stress in Parkinson's disease.
    Dias V; Junn E; Mouradian MM
    J Parkinsons Dis; 2013; 3(4):461-91. PubMed ID: 24252804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A review: traditional herbs and remedies impacting pathogenesis of Parkinson's disease.
    Sharma V; Bedi O; Gupta M; Deshmukh R
    Naunyn Schmiedebergs Arch Pharmacol; 2022 May; 395(5):495-513. PubMed ID: 35258640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The onjisaponin B metabolite tenuifolin ameliorates dopaminergic neurodegeneration in a mouse model of Parkinson's disease.
    Peng F; Lu L; Wei F; Wu D; Wang K; Tang J
    Neuroreport; 2020 Apr; 31(6):456-465. PubMed ID: 32168102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced Parkinsonian mouse model.
    Rai SN; Yadav SK; Singh D; Singh SP
    J Chem Neuroanat; 2016 Jan; 71():41-9. PubMed ID: 26686287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parkinson's disease a futile entangle of Mankind's credence on an herbal remedy: A review.
    Chang YM; Manoj Kumar M; Lu CY; Te Tsai C; Tsai CC; Liao PH; Lin SL; Chang CC; Mahalakshmi B; Kuo WW; Huang CY
    Life Sci; 2020 Sep; 257():118019. PubMed ID: 32629002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PPARβ/δ Agonist Provides Neuroprotection by Suppression of IRE1α-Caspase-12-Mediated Endoplasmic Reticulum Stress Pathway in the Rotenone Rat Model of Parkinson's Disease.
    Tong Q; Wu L; Gao Q; Ou Z; Zhu D; Zhang Y
    Mol Neurobiol; 2016 Aug; 53(6):3822-3831. PubMed ID: 26160761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antagonistic pleiotropic effects of nitric oxide in the pathophysiology of Parkinson's disease.
    Tripathy D; Chakraborty J; Mohanakumar KP
    Free Radic Res; 2015; 49(9):1129-39. PubMed ID: 25968946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroprotective effect of omega-3 polyunsaturated fatty acids in the 6-OHDA model of Parkinson's disease is mediated by a reduction of inducible nitric oxide synthase.
    Mori MA; Delattre AM; Carabelli B; Pudell C; Bortolanza M; Staziaki PV; Visentainer JV; Montanher PF; Del Bel EA; Ferraz AC
    Nutr Neurosci; 2018 Jun; 21(5):341-351. PubMed ID: 28221817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beneficial Effects of Flavonoids Against Parkinson's Disease.
    Jung UJ; Kim SR
    J Med Food; 2018 May; 21(5):421-432. PubMed ID: 29412767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multi-facetted impulsivity following nigral degeneration and dopamine replacement therapy.
    Engeln M; Ansquer S; Dugast E; Bezard E; Belin D; Fernagut PO
    Neuropharmacology; 2016 Oct; 109():69-77. PubMed ID: 27216859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nutraceuticals and their preventive or potential therapeutic value in Parkinson's disease.
    Chao J; Leung Y; Wang M; Chang RC
    Nutr Rev; 2012 Jul; 70(7):373-86. PubMed ID: 22747840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of microgliosis, oxidative stress and associated neuroinflammation in the pathogenesis of Parkinson's disease: The therapeutic role of Nrf2 activators.
    Jayaram S; Krishnamurthy PT
    Neurochem Int; 2021 May; 145():105014. PubMed ID: 33689805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Therapeutic Potential of Quercetin in Parkinson's Disease: Insights into its Molecular and Cellular Regulation.
    Tamtaji OR; Hadinezhad T; Fallah M; Shahmirzadi AR; Taghizadeh M; Behnam M; Asemi Z
    Curr Drug Targets; 2020; 21(5):509-518. PubMed ID: 31721700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nutraceuticals as Modulators of Autophagy: Relevance in Parkinson's Disease.
    Rakowski M; Porębski S; Grzelak A
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention.
    Tansey MG; McCoy MK; Frank-Cannon TC
    Exp Neurol; 2007 Nov; 208(1):1-25. PubMed ID: 17720159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Pathology of Parkinson's Disease and Potential Benefit of Dietary Polyphenols.
    Aryal S; Skinner T; Bridges B; Weber JT
    Molecules; 2020 Sep; 25(19):. PubMed ID: 32987656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.